Indirect Comparison of Darolutamide versus Apalutamide and Enzalutamide for Nonmetastatic Castration-Resistant Prostate Cancer. Halabi S, Jiang S, Terasawa E, Garcia-Horton V, et al. J Urol 2021 Apr 5:101097JU0000000000001767. doi: 10.1097/JU.0000000000001767.

Read + Share

Amedeo Smart

Independent Medical Education

Halabi S, Jiang S, Terasawa E, Garcia-Horton V, et al. Indirect Comparison of Darolutamide versus Apalutamide and Enzalutamide for Nonmetastatic Castration-Resistant Prostate Cancer. J Urol 2021 Apr 5:101097JU0000000000001767. doi: 10.1097/JU.0000000000001767.
PMID: 33818140